Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis - PubMed (original) (raw)
Ratio of serum aspartate to alanine aminotransferase in chronic hepatitis. Relationship to cirrhosis
A L Williams et al. Gastroenterology. 1988 Sep.
Abstract
The ratio of the serum aspartate to alanine amino-transferase levels (AST/ALT) is often used as a clue to the etiology of the underlying liver disease. This ratio is usually greater than 2.0 in alcoholic liver disease and less than 1.0 in patients with chronic hepatitis and chronic cholestatic syndromes. We analyzed the AST/ALT ratio in 177 patients with various forms of nonalcoholic chronic liver disease who underwent medical evaluation and percutaneous liver biopsy. In the majority of cases of chronic viral hepatitis, the AST/ALT ratio was less than 1.0. However, there was a statistically significant correlation between the AST/ALT ratio and the presence of cirrhosis. Among 100 patients with chronic type B hepatitis, the mean AST/ALT ratio was 0.59 in those without cirrhosis and 1.02 in those with cirrhosis. Furthermore, the AST/ALT ratio often rose to greater than 1.0 when cirrhosis first became manifest. Thus, the finding of an AST/ALT ratio of greater than 1.0 in a patient with nonalcoholic liver disease should suggest the presence of cirrhosis. In addition, the use of the AST/ALT ratio as a means of separating alcoholic and nonalcoholic liver disease must be tempered with the knowledge that this ratio may be less helpful in the presence of cirrhosis.
Similar articles
- Aspartate aminotransferase: alanine aminotransferase ratio in chronic hepatitis C infection: is it a useful predictor of cirrhosis?
Park GJ, Lin BP, Ngu MC, Jones DB, Katelaris PH. Park GJ, et al. J Gastroenterol Hepatol. 2000 Apr;15(4):386-90. doi: 10.1046/j.1440-1746.2000.02172.x. J Gastroenterol Hepatol. 2000. PMID: 10824882 - AST/ALT ratio > or = 1 is not diagnostic of cirrhosis in patients with chronic hepatitis C.
Reedy DW, Loo AT, Levine RA. Reedy DW, et al. Dig Dis Sci. 1998 Sep;43(9):2156-9. doi: 10.1023/a:1018888021118. Dig Dis Sci. 1998. PMID: 9753286 - Association of genetic polymorphism -670A>G in the Fas gene and serum markers AST platelet ratio index, AST/ALT with significant fibrosis and cirrhosis in chronic hepatitis C.
Deghady A, Abdou A, El-Neanaey WA, Diab I. Deghady A, et al. Genet Test Mol Biomarkers. 2012 Jun;16(6):531-5. doi: 10.1089/gtmb.2011.0098. Epub 2012 Feb 21. Genet Test Mol Biomarkers. 2012. PMID: 22352690 - [Management of asymptomatic elevated serum aminotransferase levels, particularly in nonalcoholic steatohepatitis].
Oldenburg B, Van Berge Henegouwen GP. Oldenburg B, et al. Ned Tijdschr Geneeskd. 1999 Mar 6;143(10):506-9. Ned Tijdschr Geneeskd. 1999. PMID: 10321258 Review. Dutch. - AST to ALT ratio and arterial stiffness in non-fatty liver Japanese population:a secondary analysis based on a cross-sectional study.
Liu Y, Zhao P, Cheng M, Yu L, Cheng Z, Fan L, Chen C. Liu Y, et al. Lipids Health Dis. 2018 Dec 3;17(1):275. doi: 10.1186/s12944-018-0920-4. Lipids Health Dis. 2018. PMID: 30509277 Free PMC article. Review.
Cited by
- Association of Inflammatory and Metabolic Biomarkers with Mitral Annular Calcification in Type 2 Diabetes Patients.
Grigorescu ED, Lăcătușu CM, Floria M, Cazac GD, Onofriescu A, Ceasovschih A, Crețu I, Mihai BM, Șorodoc L. Grigorescu ED, et al. J Pers Med. 2022 Sep 10;12(9):1484. doi: 10.3390/jpm12091484. J Pers Med. 2022. PMID: 36143268 Free PMC article. - Comparison of non-invasive fibrosis markers and classical liver biopsy in chronic hepatitis C.
Usluer G, Erben N, Aykin N, Dagli O, Aydogdu O, Barut S, Cevik F, Ormen B; Study Group. Usluer G, et al. Eur J Clin Microbiol Infect Dis. 2012 Aug;31(8):1873-8. doi: 10.1007/s10096-011-1513-6. Epub 2012 Jan 11. Eur J Clin Microbiol Infect Dis. 2012. PMID: 22231498 - A novel prognostic nomogram for older patients with acute-on-chronic liver diseases (AoCLD): a nationwide, multicentre, prospective cohort study.
Zou J, Li H, Deng G, Wang X, Zheng X, Chen J, Meng Z, Zheng Y, Gao Y, Qian Z, Liu F, Lu X, Shi Y, Shang J, Huang Y, Chen R. Zou J, et al. Age Ageing. 2023 Jan 8;52(1):afac313. doi: 10.1093/ageing/afac313. Age Ageing. 2023. PMID: 36626326 Free PMC article. - Inflammatory cytokine response to Vibrio vulnificus elicited by peripheral blood mononuclear cells from chronic alcohol users is associated with biomarkers of cellular oxidative stress.
Powell JL, Strauss KA, Wiley C, Zhan M, Morris JG Jr. Powell JL, et al. Infect Immun. 2003 Jul;71(7):4212-6. doi: 10.1128/IAI.71.7.4212-4216.2003. Infect Immun. 2003. PMID: 12819121 Free PMC article. - Comparison of clinical prediction rules for ruling out cirrhosis in nonalcoholic fatty liver disease (NAFLD).
Brandman D, Boyle M, McPherson S, Van Natta ML, Sanyal AJ, Kowdley K, Neuschwander-Tetri B, Chalasani N, Abdelmalek MF, Terrault NA, McCullough A, Bettencourt R, Caussy C, Kleiner DE, Behling C, Tonascia J, Anstee QM, Loomba R; Members of the Nonalcoholic Steatohepatitis Clinical Research Network. Brandman D, et al. Aliment Pharmacol Ther. 2022 Jun;55(11):1441-1451. doi: 10.1111/apt.16874. Epub 2022 Mar 17. Aliment Pharmacol Ther. 2022. PMID: 35302256 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical